The regulatory framework for pharmaceutical microbiology is at a crossroads. Novel technologies present challenges when it comes to their regulation. Cell and gene therapy products. Alternatives to in vivo testing. Alternatives to the LAL assay. Rapid microbiological methods. The list goes on.